Neoadjuvant chemoimmunotherapy for muscle-invasive bladder cancer (MIBC) followed by risk-adapted therapy led to high rates of metastasis-free survival (MFS) and bladder preservation, according to ...

Patients with localized muscle-invasive bladder cancer (MIBC) who received radiation plus the immune checkpoint inhibitors (ICIs) durvalumab (Imfinzi) and tremelimumab (Imjudo) had durable responses ...

Amid a rapidly evolving landscape in the treatment of muscle-invasive bladder cancer (MIBC), new findings presented at the ...

The standard of care for localized MIBC is radical cystectomy, the removal of the entire bladder. While it is typically effective, it can have lasting impacts on a patient’s life, explained Xavier ...

While it is typically effective, it can have lasting impacts on a patient's life, explained Garcia-del-Muro. "Radical cystectomy is a highly invasive surgery that can significantly impact patients' ...

Three-stage (group 2) 10 3.68 ± 0.55 Unilateral only 3.4 (MD) NS, baseline vs follow-up; NS group 1 vs 2 OE, prior cystectomy (group 2) 112 Not reported but all <6 cm 19.60 7.9 ± 4.2 Tubal ...

Studies from Munich University highlighted quality of life in bladder and prostate cancer at ASCO 2025 Genitourinary Cancers ...

Patient perceptions about their treatment for muscle-invasive bladder cancer (MIBC) over the last decade. PUNCH01: Interim results from a phase II study of intra-arterial chemotherapy (IAC) combined ...

Clinical efficacy of enfortumab vedotin-pembrolizumab (EV-P) in locally advanced (LA) or metastatic urothelial carcinoma (mUC): A real-world retrospective study. This is an ASCO Meeting Abstract from ...